Deals

ERT Acquires iCardiac Technologies
Date: 
Monday, December 4, 2017
Company: 
Location: 
Boston
Categories: 
B2B
Healthcare & Pharma
Deal Type: 
Acquisition

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has acquired iCardiac Technologies, a leading provider of centralized cardiac safety and respiratory solutions that accelerate clinical research. Financial terms of the transaction were not disclosed.

The acquisition enables ERT to expand its portfolio of proven cardiac safety solutions, specifically through the addition of iCardiac’s sophisticated, algorithm-driven technology, which supports efficient, cost-effective and regulatory-compliant methods of conducting QT assessments in early phase clinical trials. Through these expanded capabilities, ERT is better positioned to meet its customers’ unique needs at every phase of clinical development... READ MORE

See What It's Like To Work Here

ERT is a global data & technology company that minimizes uncertainty and risk in clinical trials so that our customers can move ahead with confidence.

More Deals From This Company

Posted on: September 8, 2017
Posted on: March 8, 2016

Similar Deals